BTI in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with BTI today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
British American Tobacco buys tobacco leaf from contracted farmers and suppliers, manufactures cigarettes, and sells tobacco and nicotine products through retail channels to adult consumers worldwide. Cigarettes and other combustible tobacco products account for most revenue. Its cigarette brands include Newport, Camel and Lucky Strike. The U.S. is its largest single market, and Newport and its other menthol cigarette brands contribute a significant share of group sales.
Its smaller smokeless business sells Vuse vaping products, glo devices and consumables that release nicotine through heating rather than burning, and Velo nicotine pouches placed between the gum and upper lip. BAT aims to encourage adult smokers who would otherwise continue smoking to switch to these products, using earnings from its combustible business to help fund the transition.
The business depends on sales volumes and its ability to raise prices as legitimate cigarette markets contract. Higher taxes, consumer affordability and cheaper illicit products limit that pricing room. Regulation restricts manufacturing, packaging, advertising, sales and use, and can prohibit products or flavours. In the U.S., continued sales of Velo products depend on FDA authorization decisions; products denied authorization generally must be withdrawn unless a court or agency intervenes.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
BAT’s results also depend on rivalry with Japan Tobacco and Imperial Brands and earnings from its substantial investment in ITC, none of which appears in this list.
Altria competes with BAT’s Reynolds business for U.S. adult consumers buying cigarettes, moist smokeless tobacco, nicotine pouches and vaping products, selling mainly through wholesalers and large retailers. Watch its Marlboro cigarette business for competitive pressure on BAT’s Newport and Camel brands.
Philip Morris International competes for BAT’s adult cigarette and nicotine customers: its heated-tobacco IQOS, nicotine pouches ZYN and vaping brand VEEV challenge glo, Velo and Vuse, respectively. Watch IQOS developments alongside glo’s rollout, as BAT says competitive pressure has affected its heated-products growth.
Universal buys and processes tobacco leaf for BAT, so BAT relies on it for part of its raw-material supply while Universal counts BAT among its six largest paying customers. Watch leaf availability and costs in Universal’s tobacco business for signs of pressure on BAT’s cigarette inputs.
Turning Point Brands competes for BAT’s U.S. adult oral-tobacco customers through Stoker’s moist snuff and for Velo customers through FRE and ALP nicotine pouches. Watch FRE and ALP sales as a sign of competition in the U.S. pouch market that drove much of BAT’s Modern Oral growth in 2025.
Philip Morris International Inc. earningsPM
Philip Morris’s report will show how its heated-tobacco and nicotine-pouch businesses compete for the same customers as BAT.
Compare Philip Morris’s heated-tobacco and nicotine-pouch businesses with the categories BAT serves through glo and Velo. Strength would point to a stronger rival for BAT in both categories; weakness would suggest less competitive pressure, but would not show how BAT’s own sales did.
Altria Group, Inc. earningsMO
Altria’s report will show how Marlboro competes with BAT for U.S. cigarette customers.
Use Altria’s Marlboro business as a signal of U.S. cigarette competition, not as a measure of BAT’s sales. Strength would mean tougher brand competition for Newport and Camel; weakness would suggest less pressure from Marlboro.
Turning Point Brands, Inc. earningsTPB
Turning Point Brands’ report will show how FRE and ALP nicotine pouches compete with BAT’s Velo for U.S. customers.
Watch FRE and ALP sales for signs that U.S. customers are choosing these nicotine pouches. Strength would mean tougher competition for Velo and BAT’s pouch growth; weakness would suggest less pressure from these brands, not that Velo sales rose.
Universal Corporation earningsUVV
Universal’s report will offer clues about tobacco-leaf supply and costs that affect BAT’s cigarette inputs.
Read Universal’s tobacco-business disclosures on leaf availability alongside costs. Tighter supply and rising costs would point to more input pressure for buyers such as BAT; ample supply and steadier costs would suggest less. Universal’s figures do not establish the prices BAT actually pays.